Axsome TherapeuticsAXSM
那斯達克 · USD
188.99
+4.80
(+2.61%)
收盤 04/18 03:59 (UTC+8)
盤後
186.00
186.00
(-1.82%)
04/18 03:59 (UTC+8)
Axsome TherapeuticsAXSM
188.99
+4.80
(+2.61%)
財務數據
損益表
- 0.58
- 0.72
- 0.75
- 0.87
- 1.05
- 1.19
- 1.21
- 1.50
- 1.71
- 1.96
- 23.76
- 23.77
- 4.85
- 16.22
- 20.19
- 13.37
- 2.27
- 23.53
- 13.96
- 14.62
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 195,999 | 170,992 | 150,042 | 121,463 | 118,766 | 104,762 | 87,166 | 74,999 | 71,530 | 57,794 |
營業成本 | 12,329 | 11,912 | 13,448 | 9,789 | 10,514 | 8,437 | 8,055 | 6,297 | 7,378 | 6,532 |
營業毛利 | 183,670 | 159,080 | 136,594 | 111,674 | 108,252 | 96,325 | 79,111 | 68,702 | 64,152 | 51,262 |
營業費用 | 210,627 | 205,189 | 173,308 | - | - | - | - | - | 162,426 | 113,382 |
研發費用 | 48,791 | 40,162 | 49,541 | 44,785 | 55,006 | 45,388 | 49,853 | 36,830 | 30,803 | 28,767 |
推銷及管理費用 | 160,229 | 163,420 | 122,178 | 122,299 | 124,256 | 111,955 | 105,714 | 97,558 | 130,016 | 83,008 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 1,607 | 1,607 | 1,589 | 1,572 | 1,607 | 1,606 | 1,590 | 1,589 | 1,607 | 1,607 |
營業利益 | -36,025 | -46,109 | -36,714 | -56,982 | -72,617 | -62,624 | -78,046 | -67,275 | -98,274 | -62,120 |
其他收入及費用 | - | - | -10,385 | - | - | - | - | - | - | - |
利息費用 | 1,172 | 1,120 | 1,834 | 2,431 | 2,210 | 1,978 | 1,299 | 1,082 | 702 | 757 |
稅前純益 | -28,129 | -47,229 | -48,933 | -59,413 | -74,827 | -64,602 | -79,345 | -68,357 | -98,976 | -62,877 |
所得稅 | 430 | - | -960 | - | 85 | - | - | - | -325 | -678 |
稅後純益 | -28,559 | -47,229 | -47,973 | -59,413 | -74,912 | -64,602 | -79,345 | -68,357 | -98,651 | -62,199 |
基本每股稅後盈餘(元) | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 |
稀釋每股稅後盈餘(元) | -0.55 | -0.95 | -0.96 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.13 | -1.34 |
基本平均股數(千股) | 50631.00 | 50021.00 | 49442.00 | 48871.00 | 48541.00 | 48140.00 | 47573.00 | 47393.00 | 47329.00 | 47117.00 |
稀釋平均股數(千股) | 50631.00 | 50021.00 | 49442.00 | 48871.00 | 48541.00 | 48140.00 | 47573.00 | 47393.00 | 47329.00 | 47117.00 |
還原基本每股稅後盈餘(元) | -0.56 | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 |
還原稀釋每股稅後盈餘(元) | -0.55 | -0.95 | -0.96 | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.13 | -1.34 |
還原基本平均股數(千股) | 50,631 | 50,021 | 49,442 | 48,871 | 48,541 | 48,140 | 47,573 | 47,393 | 47,329 | 47,117 |
還原稀釋平均股數(千股) | 50,631 | 50,021 | 49,442 | 48,871 | 48,541 | 48,140 | 47,573 | 47,393 | 47,329 | 47,117 |
EBITDA(千元) | -24,522 | -43,540 | -44,536 | -54,182 | -69,836 | -59,891 | -75,412 | -64,825 | -96,080 | -59,750 |